Please provide your email address to receive an email when new articles are posted on . Conjunctivochalasis and pterygium, two common ocular conditions associated with inflammatory changes and elastic ...
HOD HASHARON, Israel, Nov. 20, 2018 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced top ...
HOD HASHARON, Israel, April 29, 2019 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced ...